Related Experiment Video
Updated: Apr 29, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Statin use is associated with improved overall survival without affecting patency and limb salvage rates following
Hasan H Dosluoglu1, Sina Davari-Farid2, Leili Pourafkari2
1Department of Anesthesiology, SUNY-Buffalo, Buffalo, NY, USA Department of Surgery, SUNY-Buffalo, Buffalo, NY, USA.
Insights
Statin drug use in chronic limb ischemia patients undergoing revascularization was linked to better survival rates. However, statins did not significantly impact vessel patency or limb salvage outcomes.
Area of Science:
- Vascular Surgery
- Cardiology
- Pharmacology
Background:
- Chronic limb ischemia (CLI) poses significant risks for patients requiring revascularization.
- The role of statin therapy in optimizing outcomes after revascularization for CLI remains an area of investigation.
Purpose of the Study:
- To evaluate the association between statin use and outcomes including patency, limb salvage, and survival in patients with CLI undergoing revascularization.
- To identify factors independently associated with survival in this patient cohort.
Main Methods:
- Retrospective review of 717 patients who underwent revascularization for intermittent claudication or CLI between May 2001 and December 2009.
- Patients were stratified into statin and non-statin groups based on therapy at the time of revascularization.
- Comparison of early postoperative outcomes, graft patency, limb salvage rates, and survival between the groups.
Main Results:
- Of 717 patients, 397 (55.4%) were on statins. Major adverse cardiac events (MACE) were significantly lower in the statin group.
- Graft patency and limb salvage rates were comparable between statin and non-statin users.
- Survival rates were significantly higher in patients receiving statin therapy.
Conclusions:
- Statin therapy is associated with improved survival in patients undergoing revascularization for chronic limb ischemia.
- Statin use did not demonstrate a significant association with improved long-term graft patency or limb salvage rates.
- Non-statin use, coronary artery disease, COPD, renal insufficiency, critical limb ischemia, and age >70 were independent predictors of decreased survival.
Abstract:
The aim of the study was to determine statin drug association with patency, limb salvage rates and survival after revascularization in patients with chronic limb ischemia. We retrospectively reviewed all patients who underwent revascularization for intermittent claudication or critical limb ischemia between 05/2001 and 12/2009. Patients were grouped based on statin therapy at the time of revascularization. Early postoperative outcomes as well as patency, limb salvage, and survival rates were compared between groups. Of 717 patients, 397 (55.4%) were on statins. The incidence of major adverse cardiac events (MACE) was significantly lower in the statin group. Patency and limb salvage rates were similar; however, survival was significantly better in the statin group. Non-statin use, coronary artery disease, chronic pulmonary obstructive disease, renal insufficiency, critical limb ischemia, and age >70 years were found to be independently associated with decreased survival. Statin use was associated with improved survival, but not with long-term patency and limb salvage.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease V: Postoperative Nursing Management
